Noticias de FATE_US

Noticias del mercado

Últimas noticias sobre FATE_US — 118 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: FATE_US ✕ 118 resultados
01/05/2026 FATE_US — Yahoo Finance
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
30/04/2026 FATE_US — GlobeNewswire ES ← EN
Fate Therapeutics anuncia la presentación de datos de FT819

Fate Therapeutics Announces Data Presentation of FT819

30/04/2026 FATE_US — GlobeNewswire
Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting
30/04/2026 FATE_US — ChartMill
Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting
30/04/2026 FATE_US — Stock Titan
Single-dose FT819 data in 10 lupus patients heads to rheumatology meeting
24/04/2026 FATE_US — openPR.com
iPSC-Derived NK Cells Pipeline Set to Transform Cancer
24/04/2026 FATE_US — Stock Titan
Fate Therapeutics (NASDAQ: FATE) sets 2026 proxy votes and 7M-share plan boost
24/04/2026 FATE_US — Stock Titan
[ARS] FATE THERAPEUTICS INC SEC Filing
23/04/2026 FATE_US — Barchart.com
iPSC-Derived NK Cells Pipeline Set to Transform Cancer Immunotherapy Landscape with 15+ Emerging Therapies and Strong Innovation Momentum from Century Therapeutics, Fate Therapeutics | DelveInsight
23/04/2026 FATE_US — Barchart.com
iPSC-Derived NK Cells Pipeline Set to Transform Cancer Immunotherapy Landscape with 15+ Emerging Therapies and Strong Innovation Momentum from Century Therapeutics, Fate Therapeutics | DelveInsight
23/04/2026 FATE_US — Stock Titan
Redmile (NASDAQ: FATE) corrects cash-settled swap reference price
22/04/2026 FATE_US — Stock Titan
Redmile reshapes Fate Therapeutics (NASDAQ: FATE) stake in exit filing
22/04/2026 FATE_US — Stock Titan
Redmile (NASDAQ: FATE) shifts stake to SPV in internal reorg
20/04/2026 FATE_US — news.google.com
Fate Therapeutics (FATE) Stock: Why Market Expansion (Breakdown Watch) 2026-04-20 - Social Buzz
20/04/2026 FATE_US — tayninh.gov.vn
Fate Therapeutics (FATE) Stock: Why Market Expansion (Breakdown Watch) 2026-04-20 - Social Buzz
20/04/2026 FATE_US — Xã Thanh Hà
Fate Therapeutics (FATE) Stock: Why Market Expansion (Breakdown Watch) 2026-04-20 - Social Buzz
20/04/2026 FATE_US — laocai.gov.vn ES ← EN
Acciones de Fate Therapeutics (FATE): Por qué la expansión del mercado (observación de desgloses) 2026-04-20 - Social Buzz
20/04/2026 FATE_US — sonla.gov.vn
Fate Therapeutics (FATE) Stock: Why Market Expansion (Breakdown Watch) 2026-04-20 - Social Buzz
20/04/2026 FATE_US — Newser
Fate Therapeutics (FATE) Stock: Why Market Expansion (Breakdown Watch) 2026-04-20 - Fundamental Analysis
17/04/2026 FATE_US — Sahm
Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at t

Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at…

Página 4 de 6

keyboard_arrow_up